About
Technology
Issues
FAQ
Links
Official Page
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.